CDC Again Advises against Nasal Spray Flu Vaccine
June 28, 2017 | Strategic Insights for Health System
The Centers for Disease Control and Prevention (CDC) advised against the use of FluMist, the nasal spray flu vaccine (i.e., live attenuated influenza vaccine), for the 2017-2018 season, according to a June 21, 2017, article on CNN.com. CDC issued the recommendation at a meeting of its Advisory Committee on Immunization Practices on June 21 and 22. At the 2016 meeting, CDC introduced a study that showed the nasal spray vaccine to be ineffective (see HRC Alerts, June 29, 2016: Nasal Spray Vaccine Should Not Be Used in the 2016-2017 Flu Season, Says CDC). Although the nasal spray vaccine is not recommended, it is still approved by the U.S. Food and Drug Administration for patients between the ages of 2 and 49.